Shang Hao Jia Soda Biscuit recall — FDA H-0455-2025
Various snack cracker products are mislabeled and do not declare all allergen ingredients (Whole Milk Powder and wheat).
Complete FDA and NHTSA recall records dated in 2025, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Various snack cracker products are mislabeled and do not declare all allergen ingredients (Whole Milk Powder and wheat).
Product may contain small metal fragments due to contaminated onion powder ingredient used in manufacturing.
Product was manufactured and held under insanitary conditions. Product may be contaminated with Listeria monocytogenes.
Potential contamination with foreign objects (metal pieces).
Tuna Salad products are recalled due to potential contamination with Listeria monocytogenes because products containing Newly Weds Foods recalled Japanese Style Breadcrumbs.
Tuna Salad products are recalled due to potential contamination with Listeria monocytogenes because products containing Newly Weds Foods recalled Japanese Style Breadcrumbs.
Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
Failed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the long-term shelf life stability interval,…
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.
Chrysler (FCA US, LLC) is recalling certain 2026 Ram 3500, 3500 Cab Chassis, 2500, 4500 Cab Chassis, and 5500 Cab Chassis vehicles. The instrument panel may display an incorrect brake…
Foreign Material (wood)
Pecans have the potential to be contaminated with Salmonella,
Temperature abuse due to temperature excursion in one shipping trailer
Temperature abuse due to temperature excursion in one shipping trailer
Inaccurate temperature reading from a thermometer on one pasteurization machine
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.